Company: STAA
Filing Date: 2025-10-30
Form Type: DEFA14A
Source: 0001193125-25-258558
Chunk: 28

Company: STAAR SURGICAL CO
Filing Date: 2025-10-30
Form: DEFA14A
Chunk 28
---
2019        |     | Stryker Corporation           |     | Wright Medical Group N.V.    |
| 08/30/2018        |     | Stryker Corporation           |     | K2M Group Holdings, Inc.     |

Although none of the target companies in the selected transactions are directly comparable to STAAR and none of the selected transactions are directly comparable to the transactions contemplated by the Merger Agreement, the selected transactions were chosen because they involved businesses with financial, operational or business characteristics that, in Citi’s view, based on its professional judgment and experience, made them sufficiently comparable to STAAR and/or the transaction contemplated by the Merger Agreement or otherwise relevant for purposes of analysis. For each of the selected transactions, Citi reviewed, among other information, enterprise value as a multiple of the applicable target company’s most recently disclosed last 12 months revenue (“LTM revenue”) as of the announcement date of the relevant transaction (such multiples, “EV / LTM Revenue” multiples). Financial data of the selected transactions were based on public filings and other publicly available information. The overall low to high EV / LTM Revenue multiples observed for the selected transactions were 3.1x to 6.3x (with a median of 5.9x). The results of this review were as follows:

| Announcement Date |     | Acquiror                      |     | Target                       |     | Transaction Value 
 ($ in billions)   |     |     | EV /LTM 
 Revenue |      |
|:------------------|:----|:------------------------------|:----|:-----------------------------|:----|:------------------|----:|:----|:--------|:-----|
| 03/24/2025        |     | Alcon Inc.                    |     | LENSAR, Inc.                 |     | $                 | 0.3 |     |         | 6.2x |
| 06/18/2024        |     | Boston Scientific Corporation |     | Silk Road Medical, Inc.      |     | $                 | 1.2 |     |         | 6.3x |
| 02/09/2023        |     | Abbott Laboratories           |     | Cardiovascular Systems, Inc. |     | $                 | 0.7 |     |         | 3.1x |
| 01/12/2021        |     | STERIS plc                    |     | Cantel Medical Corp.